US demand for in vitro diagnostic (IVD) products is forecast to increase 5.4 percent annually through 2013. Clinical chemistry and immunoassay will remain the top two IVD methodologies. Nucleic acid testing products will generate the fastest demand gains while endocrine condition testing remains the largest application.
This study analyzes the $17.6 billion US IVD industry. It presents historical demand data for the years 1998, 2003 and 2008, and forecasts for 2013 and 2018 by product type (e.g., reagents and consumables, instruments and systems, clinical chemistry, immunoassay, blood testing, nucleic acid testing, microbiology, cellular analysis), application (e.g., endocrine conditions, infectious diseases, cancer, drug testing) and market.
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 22 industry players, including Johnson & Johnson, Roche Holding and Siemens Healthcare Diagnostics.